伴同型半胱氨酸升高的高血压——“H型”高血压

被引：225

作者：

张岩

霍勇

机构：

[1] 北京大学第一医院心内科

来源：

心血管病学进展 | 2011年 / 32卷 / 01期

关键词：

高血压; 同型半胱氨酸; 叶酸;

D O I：

暂无

中图分类号：

R544.1 [高血压];

学科分类号：

1002 ; 100201 ;

摘要：

高同型半胱氨酸血症是冠状动脉粥样硬化性心脏病、脑卒中等心脑血管疾病的危险因素,伴有血浆同型半胱氨酸水平升高的高血压被定义为"H型"高血压,约占我国成年高血压患者的75%。"H型"高血压的治疗应同时降低血压和血浆同型半胱氨酸的水平。降低同型半胱氨酸最有效的方法是补充叶酸,并可能减少心脑血管事件的发生。

引用

页码：3 / 6

页数：4

共 30 条

[1]

Homocysteine lowering with folic acid and B vitamins in vascular disease. E. Lonn,S. Yusuf,M.J. Arnold. The New England Journal of Medicine . 2006

[2] Cardiovascular morbidity and mortality in the atherosclerosis and folic acid supplementation trial (ASFAST) in chronic renal failure [J].

Zoungas, S ;

McGrath, BP ;

Branley, P ;

Kerr, PG ;

Muske, C ;

Wolfe, R ;

Atkins, RC ;

Nicholls, K ;

Fraenkel, M ;

Hutchison, BG ;

Walker, R ;

McNeil, JJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (06) :1108-1116

[3] 马来酸依那普利叶酸片降压、降同型半胱氨酸的疗效和安全性 [J].

李建平 ;

霍勇 ;

刘平 ;

秦献辉 ;

关德明 ;

葛均波 ;

胡健 ;

王燕妮 ;

张馥敏 ;

毛广运 ;

徐希平 .

北京大学学报(医学版), 2007, (06) :614-618

[4]

Effects of loweringhomocysteine levelswith B vitamins on cardiovascular disease,cancer,and cause-specific mortali-ty:meta-analysis of8 randomized trials involving37 485 individuals. Clarke R,Halsey J,Lewington S,etal. Archives of Internal Medicine . 2010

[5]

Blinded comparison of folic acid andplacebo in patients with ischaemic heart disease:an outcome trial[abstract]. Baker F,Picton D,Blackwood S,et al. Circulation . 2002

[6]

Effect of homocysteine loweringon mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease:a randomized controlled trial. Jamison RL,Hartigan P,Kaufman JS,et al. The Journal of The American Medical Association . 2007

[7]

Gene polymorphisms and risk of adult early-onset ischemic stroke:a meta-analysis. Xin XY,Song YY,Ma JF,et al. Thrombosis Research . 2009

[8]

China Stroke Primary Prevention Trial. http://clinicaltrials.gov/ct2/results?term=NCT00794885 .

[9]

Plasma homocysteine and coronary heart disease:systematic review of published epidemiologic studies. Danesh,J,Lewington,S. Journal of Cardiovascular Risk . 1998

[10]

High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Zhang W,Sun K,Chen J,et al. Clinical Science Lond . 2009

← 1 2 3 →